RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study

• Florence Le Calvez-Kelm,

  Affiliation Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Javier Oliver,

  Affiliation Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Francesca Damiola,

  Affiliation Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Nathalie Forey,

  Affiliation Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Nivonirina Robinot,

  Affiliation Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Geoffroy Durand,

  Affiliation Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Catherine Voegele,

  Affiliation Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Maxime P. Vallée,

  Affiliation Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Graham Byrnes,

  Affiliation Biostatistics Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Breast Cancer Family Registry,

  Affiliations Center for Molecular, Environmental, Genetic and Analytical Epidemiology, School of Population Health, EGA The University of Melbourne, Victoria, Australia, Genetic Epidemiology Laboratory, The University of Melbourne, Victoria, Australia, Department of Molecular Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada, Cancer Prevention Institute of California, Fremont, California, United States of America, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, California, United States of America

  ⨯
• John L. Hopper,

  Affiliation Center for Molecular, Environmental, Genetic and Analytical Epidemiology, School of Population Health, EGA The University of Melbourne, Victoria, Australia

  ⨯
• Melissa C. Southey,

  Affiliation Genetic Epidemiology Laboratory, The University of Melbourne, Victoria, Australia

  ⨯
• Irene L. Andrulis,

  Affiliation Department of Molecular Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯
• Esther M. John,

  Affiliations Cancer Prevention Institute of California, Fremont, California, United States of America, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, California, United States of America

  ⨯
• Sean V. Tavtigian,

  Affiliation Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America

  ⨯
•  [ ... ],
• Fabienne Lesueur

  * E-mail: lesueurf@iarc.fr

  Affiliation Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• [ view all ]
• [ view less ]